Cargando…
Elimination of senescent osteoclast progenitors has no effect on the age‐associated loss of bone mass in mice
Both an increase in osteoclast and a decrease in osteoblast numbers contribute to skeletal aging. Markers of cellular senescence, including expression of the cyclin inhibitor p16, increase with aging in several bone cell populations. The elimination of p16‐expressing cells in old mice, using the INK...
Autores principales: | Kim, Ha‐Neui, Chang, Jianhui, Iyer, Srividhya, Han, Li, Campisi, Judith, Manolagas, Stavros C., Zhou, Daohong, Almeida, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516158/ https://www.ncbi.nlm.nih.gov/pubmed/30773784 http://dx.doi.org/10.1111/acel.12923 |
Ejemplares similares
-
DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age
por: Kim, Ha‐Neui, et al.
Publicado: (2017) -
Mmp13 deletion in mesenchymal cells increases bone mass and may attenuate the cortical bone loss caused by estrogen deficiency
por: Ponte, Filipa, et al.
Publicado: (2022) -
Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors
por: Kim, Ha-Neui, et al.
Publicado: (2020) -
A decrease in NAD(+) contributes to the loss of osteoprogenitors and bone mass with aging
por: Kim, Ha-Neui, et al.
Publicado: (2021) -
Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence
por: Kim, Ha-Neui, et al.
Publicado: (2020)